These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31448224)

  • 21. Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells.
    Wang J; Wang P; Zhang T; Gao Z; Wang J; Feng M; Yin R; Zhang H
    Blood Sci; 2019 Aug; 1(1):77-83. PubMed ID: 35402786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD200 expression marks leukemia stem cells in human AML.
    Ho JM; Dobson SM; Voisin V; McLeod J; Kennedy JA; Mitchell A; Jin L; Eppert K; Bader G; Minden MD; Dick JE; Wang JCY
    Blood Adv; 2020 Nov; 4(21):5402-5413. PubMed ID: 33147339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis.
    Liu Z; Spiegelman VS; Wang HG
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1592. PubMed ID: 34862757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
    Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
    Elife; 2020 Jan; 9():. PubMed ID: 31985402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity.
    Yassin M; Aqaqe N; Yassin AA; van Galen P; Kugler E; Bernstein BE; Koren-Michowitz M; Canaani J; Nagler A; Lechman ER; Dick JE; Wienholds E; Izraeli S; Milyavsky M
    Leukemia; 2019 Aug; 33(8):2061-2077. PubMed ID: 30705411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-binding proteins as drivers of AML and novel therapeutic targets.
    Qin T; Cheng Y; Wang X
    Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A global screening identifies chromatin-enriched RNA-binding proteins and the transcriptional regulatory activity of QKI5 during monocytic differentiation.
    Ren Y; Huo Y; Li W; He M; Liu S; Yang J; Zhao H; Xu L; Guo Y; Si Y; Zhao H; Rao S; Wang J; Ma Y; Wang X; Yu J; Wang F
    Genome Biol; 2021 Oct; 22(1):290. PubMed ID: 34649616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles.
    Trino S; Laurenzana I; Lamorte D; Calice G; De Stradis A; Santodirocco M; Sgambato A; Caivano A; De Luca L
    Front Oncol; 2022; 12():824562. PubMed ID: 35371979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
    Chopra M; Bohlander SK
    Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human protein-RNA interaction network is highly stable across mammals.
    Ramakrishnan A; Janga SC
    BMC Genomics; 2019 Dec; 20(Suppl 12):1004. PubMed ID: 31888461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox17 as a candidate regulator of myeloid restricted differentiation potential.
    Anani M; Nobuhisa I; Osawa M; Iwama A; Harada K; Saito K; Taga T
    Dev Growth Differ; 2014 Aug; 56(6):469-79. PubMed ID: 25093513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
    Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
    Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
    Crews LA; Balaian L; Delos Santos NP; Leu HS; Court AC; Lazzari E; Sadarangani A; Zipeto MA; La Clair JJ; Villa R; Kulidjian A; Storb R; Morris SR; Ball ED; Burkart MD; Jamieson CHM
    Cell Stem Cell; 2016 Nov; 19(5):599-612. PubMed ID: 27570067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection.
    Srinivasan Rajsri K; Roy N; Chakraborty S
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.